Sermorelin Acetate is a highly purified, synthetically produced 29-amino acid polypeptide corresponding to the amino-terminal fragment of endogenous Growth Hormone-Releasing Hormone (GHRH). Formulated as an acetate salt for enhanced structural stability during laboratory assays. For laboratory and in vitro research use only. Not for human consumption. Not a medicine.
Sermorelin Acetate (also structurally designated as GRF 1-29) is the shortest fully functional fragment of natural Growth Hormone-Releasing Hormone. It contains the core 29-amino acid sequence necessary to bind and stimulate target receptors on pituitary somatotrophs. In laboratory environments, this agent is utilized to map endocrine pathways, study negative feedback control structures via somatostatin tracking, and evaluate raw pulsatile hormone secretion without overriding natural safety systems.
Mechanistic & Cellular Target Channels
Pituitary GHRH Receptor Agonism: Binds specifically to G-protein coupled receptors on somatotrophic cells, triggering the cyclic adenosine monophosphate (cAMP) downstream signaling loop.
Pulsatile Secretion Replication: Simulates natural, physiological release patterns of growth hormone rather than flooding test systems, preserving regular feedback loops during observation.
Somatostatin Regulation Mapping: Allows investigators to study cellular responses to inhibitory signaling vectors across prolonged preclinical trials.
Primary Laboratory Research Applications
Pituitary function modeling and endogenous secretagogue signaling kinetics.
Cellular longevity, tissue repair, and lean mass density modulation mapping.
Comparative analysis of GHRH vs GHRP (Growth Hormone Releasing Peptides) pathway cascades.
Sleep cycle pathomechanics and neuroendocrine regulation analysis.
Analytical Verification Specifications
Structural Core:
GHRH Fragment Region (1-29 Amino Acid Sequence)
Available Masses:
5mg (5,000 mcg) or 10mg (10,000 mcg)
Purity Benchmark:
≥99.0% (HPLC & Mass Spectrometry Verified)
Salt Variant:
Acetate Salt Matrix (Optimizes structural longevity)
Formulation Vector:
Lyophilized Vacuum Solid Cake
⚠️ Preclinical Integrity Notice
All laboratory assets documented within this registry are distributed exclusively for verified laboratory research, analytical control trials, and foundational in vitro testing models. These chemical compounds are strictly not approved for human therapeutic, clinical, veterinary, or diagnostic administration.
Dosage
5MG, 10MG
Class
Growth Hormone-Releasing Hormone (GHRH) Analog
Purity
≥99.0% Purity (HPLC Verified)
Form
Lyophilized Solid Powder (Acetate Salt form for stability)
